Search - tctmd.com

Displaying 141 - 160 of 313

Sort: Relevancy | Date

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

News Daily News

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

November 17, 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

News Conference News HFSA 2022

New Dapagliflozin Insights: Early Benefits and Types of Deaths Prevented

October 07, 2022

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

News Daily News

Older Adults See Rebound in Rates of HF-Related Death: CDC Data

September 09, 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

News Conference News ESC 2022

DELIVER Results, Other Analyses Bolster SGLT2 Inhibitors Across HF Spectrum

August 27, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

Women With Early Menopause See Higher Heart Failure, AF Risks

News Daily News

Women With Early Menopause See Higher Heart Failure, AF Risks

Yael L. Maxwell

August 04, 2022

HF Deaths on the Rise in Young Adults, US Data Show

News Daily News

HF Deaths on the Rise in Young Adults, US Data Show

August 03, 2022

Early LV Recovery After TAVI Points to Better 5-Year Survival

News Daily News

Early LV Recovery After TAVI Points to Better 5-Year Survival

Yael L. Maxwell

August 01, 2022

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

News Daily News

Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds

July 25, 2022

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

News Daily News

Black and Hispanic Patients Not Accessing High-Volume TEER Centers

Michael O'Riordan

July 19, 2022

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

News Daily News

Shock in Peripartum Cardiomyopathy Especially Risky in Black, Hispanic Patients

July 13, 2022

Postop AF Portends Higher Risk of HF Hospitalization in the Next Few Years

News Daily News

Postop AF Portends Higher Risk of HF Hospitalization in the Next Few Years

June 30, 2022

Heart Failure Risks of Smoking Can Linger for Decades

News Daily News

Heart Failure Risks of Smoking Can Linger for Decades

June 07, 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

May 23, 2022

Dapagliflozin Boosts Health Status Across LVEF Range

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

May 23, 2022

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

May 05, 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

May 02, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.